DK1575559T3 - Doseringsaerosoler med lecithin som overfladeaktivt stof - Google Patents

Doseringsaerosoler med lecithin som overfladeaktivt stof

Info

Publication number
DK1575559T3
DK1575559T3 DK03799507T DK03799507T DK1575559T3 DK 1575559 T3 DK1575559 T3 DK 1575559T3 DK 03799507 T DK03799507 T DK 03799507T DK 03799507 T DK03799507 T DK 03799507T DK 1575559 T3 DK1575559 T3 DK 1575559T3
Authority
DK
Denmark
Prior art keywords
lecithin
surfactant
dosage aerosols
aerosols
dosage
Prior art date
Application number
DK03799507T
Other languages
Danish (da)
English (en)
Inventor
Franz Guck
Gieselher Warnke
Original Assignee
Ig Spruehtechnik Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ig Spruehtechnik Gmbh & Co Kg filed Critical Ig Spruehtechnik Gmbh & Co Kg
Application granted granted Critical
Publication of DK1575559T3 publication Critical patent/DK1575559T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK03799507T 2002-12-24 2003-12-24 Doseringsaerosoler med lecithin som overfladeaktivt stof DK1575559T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10260882A DE10260882B4 (de) 2002-12-24 2002-12-24 Dosieraerosole mit Sojalecithin als oberflächenaktiver Substanz und dessen Verwendung

Publications (1)

Publication Number Publication Date
DK1575559T3 true DK1575559T3 (da) 2006-11-27

Family

ID=32667543

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03799507T DK1575559T3 (da) 2002-12-24 2003-12-24 Doseringsaerosoler med lecithin som overfladeaktivt stof

Country Status (12)

Country Link
US (1) US20060073103A1 (fr)
EP (1) EP1575559B1 (fr)
JP (1) JP2006517190A (fr)
CN (1) CN1728984A (fr)
AT (1) ATE335467T1 (fr)
AU (1) AU2003300230A1 (fr)
DE (2) DE10260882B4 (fr)
DK (1) DK1575559T3 (fr)
ES (1) ES2270166T3 (fr)
IL (1) IL169356A0 (fr)
TW (1) TW200423969A (fr)
WO (1) WO2004058221A1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292499A (en) * 1990-09-11 1994-03-08 University Of Wales College Of Cardiff Method of preparing medical aerosol formulations including drug dissolved in reverse micelles
GB9118830D0 (en) * 1991-09-03 1991-10-16 Minnesota Mining & Mfg Medical aerosol formulations
JP2001511160A (ja) * 1997-02-05 2001-08-07 ヤゴ リサーチ アクチェンゲゼルシャフト 医学用エアゾール配合物
US6017545A (en) * 1998-02-10 2000-01-25 Modi; Pankaj Mixed micellar delivery system and method of preparation
ES2234266T3 (es) * 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
US6312665B1 (en) * 1998-12-21 2001-11-06 Generex Pharmaceuticals Incorporated Aerosol formulations for buccal and pulmonary application
DE19911064A1 (de) * 1999-03-12 2000-09-14 Ig Spruehtechnik Gmbh Dosieraerosole mit Isobutan als Treibmittel

Also Published As

Publication number Publication date
ES2270166T3 (es) 2007-04-01
IL169356A0 (en) 2007-07-04
EP1575559A1 (fr) 2005-09-21
CN1728984A (zh) 2006-02-01
TW200423969A (en) 2004-11-16
WO2004058221A1 (fr) 2004-07-15
DE50304615D1 (de) 2006-09-21
ATE335467T1 (de) 2006-09-15
US20060073103A1 (en) 2006-04-06
AU2003300230A1 (en) 2004-07-22
DE10260882A1 (de) 2004-09-30
DE10260882B4 (de) 2007-02-08
JP2006517190A (ja) 2006-07-20
EP1575559B1 (fr) 2006-08-09

Similar Documents

Publication Publication Date Title
NO2025027I1 (no) Pharmaceutical mixture or association that includes as active ingredients: (1) ceftazidime or a salt thereof, and (2) avibactam or a pharmaceutically acceptable salt thereof - forlenget.
CY1111821T1 (el) Φαρμακευτικες συνθeσεις οι οποιες περιλαμβανουν ενα οπιουχο αναλγητικο
CL2008002407A1 (es) Forma de dosificacion oral que comprende al menos un agente activo de nicotina, al menos un material bioadhesivo capaz de formar un enlace de hidrogeno con el agente activo de nicotina, y al menos un agente de impacto sensorial que se libere rapidamente; y su uso para proporcionar alivio rapido de las ansias de nicotina (div. sol. 1825-04).
DE60019167D1 (de) Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
AP2003002916A0 (en) HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis.
ATE342053T1 (de) Formulierungen zur inhalation
ES2189410T3 (es) Formulacion farmaceutica en aerosol.
DK1363641T3 (da) Progestagen, der er co-mikroniseret med et overfladeaktivt middel, farmaceutisk præparat, som indeholder det, fremgangsmåder til fremstilling deraf samt anvendelser deraf
BR0207025B1 (pt) derivado de isoxazolina e herbicida contendo o mesmo como o ingrediente ativo.
UA88477C2 (ru) Композиция пеллеты пролонгированного высвобождения, которая содержит прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
DE60311920D1 (de) Aufgabevorrichtung mit Dosierkammer sowie Aerosolspender mit derselben
DK1608336T3 (da) Formulering til en doseringsinhalator med hydrofluorakaner som drivmidler
NO992102L (no) Peptidblanding, samt farmasøytisk sammensetning og kreftvaksine som innbefatter peptidblandingen
ECSP077126A (es) Formulaciones en suspensión de aerosol con tg 227 ea o tg 134 a como agentes propulsores
USD529537S1 (en) Type font
WO2003102012A3 (fr) Nouveaux esters d'etonogestrel
ITMI20000010A0 (it) Dispositivo per la somministrazione di aerosol dosati pressurizzati in propellenti idrofluoroalcani
DE60324205D1 (de) Wasserlöslicher behälter
DE60136637D1 (en) Topische polymere antimikrobielle emulsion
AR038560A1 (es) Una composicion antitranspirante/ desodorante
ITRM20020477A1 (it) Procedimento per la realizzazione di un fantoccio stereolitografato biomorfo, multicompartimentale e per esami multianalitici, e relativo dispositivo.
ITPR20020027A1 (it) Ampolla nebulizzatrice, in particolare per aerosolterapia.
DK1575559T3 (da) Doseringsaerosoler med lecithin som overfladeaktivt stof
NO20052478D0 (no) Vitamin D-analoger, sammensetninger omfattende analogene og deres anvendelse.
NO20053110D0 (no) 2-oksyamino-1-cyklopenten-1-nitriler som materialbeskyttelsesmidler.